Clinical outcomes of patients with KMT2A-rearranged ALL. OS (A) and RFS (B) according to the type of KMT2A rearrangement. OS (C) and RFS (D) according to MRD status at time of CR. OS (E) and RFS (F) with landmark analysis for HSCT in CR1.